News - Helio Genomics
See what we're up to
in the news.

Stay up to date with how Helio is transforming the paradigm of early cancer detection.

Hot off the press

Read our latest stories from the newsroom.

Health Tech: Shu Li On How Helio Health’s Technology Can Make An Important Impact On Our Overall Wellness

June 10, 2022

Helio Genomics honored with second consecutive MedTech Breakthrough Award as “Best New Biopsy Technology Solution

May 05, 2022

Dr. Mindie H. Nguyen, Professor of Medicine (Gastroenterology and Hepatology) at Stanford Health Care, speaks about Helio’s recent peer-reviewed publication of the ENCORE trial in Hepatology Communications, where HelioLiver demonstrated superior performance in the early detection of liver cancer.

April 20, 2022

Our new patient hub for HelioLiver is now live! Learn about the stages of liver disease and how early detection can save lives, along with tips to manage a healthy liver and active patient advocacy groups to connect with.

April 19, 2022

In honor of World Liver Day, we're bringing attention to the importance of taking control of your liver health. This starts with creating a liver care plan and keeping close tabs on your risk for liver cancer, especially if you have pre-existing cirrhosis or HBV.

April 19, 2022

Catching cancer early is the key to saving lives, yet current detection tools are poor predictors of early stage disease. At Helio, we are seeking to change that. Learn how we are working toward a future of widely accessible cancer detection through a simple blood draw.

March 01, 2022

Richard A. Van Etten MD, Ph.D., Director of the NCI-designated Chao Family Comprehensive Cancer Center, speaks to OncologyTube about recent positive performance data of HelioLiver™ for Early Liver Cancer Detection.

December 01, 2021

Meet The Expert: Dr. Robert Gish

October 10, 2021

Fulgent Genetics and Helio Genomics Announce Strategic Partnership to Commercialize Early Cancer Detection Tests

August 09, 2021

Webcast of Helio Genomics Fireside Chat at the 2021 BTIG Virtual MedTech, Digital health, Life Science & Diagnostic Tools Conference

February 17, 2021

CFO brings repeat-business mindset, honed at Amazon Prime, to cancer-testing startup

June 14, 2020

Podcast: Improving Cancer Outcomes with Early Diagnosis

March 27, 2020

Detect Cancer Early: Liquid Biopsy Based ctDNA Methylation as a Promising Diagnostic Approach

March 27, 2020

At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus

February 21, 2020

Podcast Interview with Kenneth Chahine, CEO"

February 18, 2020

ctDNA Methylation Profiles Power Effective Colorectal Cancer Diagnosis, Prognosis, and Screening

January 03, 2020

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancerc

January 03, 2020

Circulating Tumor DNA Methylation Profiles May Aid in Colorectal Cancer Early Diagnosis, Prognosis

January 02, 2020

Circulating Tumor DNA Methylation Profiles May Aid in Colorectal Cancer Early Diagnosis, Prognosisc

January 02, 2020

LAM's Liquid Biopsy Test of cfDNA Methylation Panel Enables Highly Sensitive and Specific Detection of the Most Common Liver Cancer (Hepatocellular Carcinoma)

December 17, 2019

Lab Raises $86 Million for ‘Breakthrough’ Liver Cancer Testcc

November 25, 2019

Cancer Diagnostic Firm LAM on Growth Path

November 11, 2019

AncestryDNA chief takes on liquid biopsy challenge; Thomas Lynch chairs former colleague’s cancer startup

November 08, 2019

Laboratory For Advanced Medicine Appoints New CEO, Prepares To Scale Liquid Biopsy Pipeline

November 07, 2019

Cancer-Testing Startup Hires Veteran as CEO, Raises $86 Million

November 07, 2019

A Blood Test for Cancerc

October 01, 2019

Laboratory for Advanced Medicine’s liver cancer test gets FDA breakthrough tag

September 04, 2019

Early Detection is Key to Successc

July 18, 2019

Early Cancer Detection: Is This Company Ahead of Grail?

July 08, 2019

Biomarkers Being Identified for Improved Diagnosis of Nasopharyngeal Carcinoma Via Liquid Biopsy

June 21, 2019

Finding the Right Markers for Cancer Diagnosis

June 18, 2019

Detect Cancer and Halt it in its Tracks

June 12, 2019

Noninvasive Test of Cell-Free Methylated DNA Markers Shows High Sensitivity and Specificity in Detection of Nasopharyngeal Carcinoma (NPC)

June 11, 2019

Liquid Biopsy Platform Demonstrates High Diagnostic Capabilities In Early Stages of Nasopharyngeal Carcinoma

May 31, 2019

DNA Methylation Analysis for Early Detection of Various Cancers

May 29, 2019

LAM Aims to Apply Methylation Cancer Testing to Blood

April 29, 2019

Blood Test for Early Stage Cancer Diagnosis: Interview with Dr. Van Etten, CMO of Laboratory for Advanced Medicine

March 14, 2019

Laboratory for Advanced Medicine Plans More Cancer Tests, More Hires

January 24, 2019

Blood test offers early detection for cancer patients

October 28, 2018

New York Onco-Immunologist Pioneers the Use of Advanced Cancer Test: IvyGene

October 12, 2018

Research underlying LAM’s IvyGene test shows liquid biopsy is the answer to liver cancer – Technology Networks

October 04, 2018

Introducing IvyGene: \"Patient-Friendly\" Advancement in Early Cancer Detection

September 19, 2018

June 01, 2018

May 21, 2018

Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

May 11, 2018

Mission to offer cancer screenings for firefighters

April 13, 2018

LAM’s research collaborators at UCSD prove that non-invasive blood testing may find liver cancer earlier and improve survival – San Diego Union Tribune

October 09, 2017

Liquid biopsy may be new way to detect liver cancer earlier, easier

October 09, 2017
Helio Genomics ribbon
Need More Info?
We’re happy to hear from you and answer any questions you have about Helio.